PHAXIAM Therapeutics S.A. - ADR
PHAXIAM Therapeutics S.A. - ADR Stock, NASDAQ:PHXM
Phaxiam Therapeutics SA is a biopharmaceutical company, which develops red blood cell-based therapeutics for severe forms of cancer and orphan diseases. It operates through the following technical platforms: ERYCAPS, ERYCEV and ERYTECH. The ERYCAPS which uses a novel technology to encapsulate drug substances inside red blood cells. The ERYCEV focuses on potential of drug-loaded extracellular vesicles, derived from red blood cells. ERYTECH developing product candidates for patients with unmet medical needs. The company was founded in 2004 and is headquartered in Lyon, France.